Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald ...

Is ANI Pharmaceuticals (ANIP) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this ...

Truist analyst Les Sulewski raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $65 from $62 and keeps a Hold rating on the shares ...

Here are four stocks that made it through the screen: ANI Pharmaceuticals represents a compelling investment opportunity in 2025 as it strategically strengthens its Rare Disease portfolio and ...

ANI Pharmaceuticals stock opened at $68.12 on Friday. ANI Pharmaceuticals has a 52-week low of $52.50 and a 52-week high of $70.00. The company has a market cap of $1.48 billion, a price-to ...

Even during a down period for the markets, ANI Pharmaceuticals has gone against the grain, climbing to $68.06. Its shares have yielded a 16.1% return over the last six months, beating the S&P 500 by ...

During the last three months, 6 analysts shared their evaluations of ANI Pharmaceuticals ANIP, revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their ...

ANI Pharmaceuticals has a 12 month low of $52.50 and a 12 month high of $70.00. The stock has a market capitalization of $1.44 billion, a P/E ratio of -120.02 and a beta of 0.49.